PRIA Logo™
117-hr-8641117th Congress

Orphan Drug COVID–19 Mitigation Act of 2022

Sponsored By: Representative Gottheimer, Josh [D-NJ-5]

Unknown

Summary

Orphan Drug COVID-19 Mitigation Act of 2022 This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Gottheimer, Josh [D-NJ-5]

NJ • D

Cosponsors

  • Rep. Bacon, Don [R-NE-2]

    NE • R

    Sponsored 8/2/2022

  • Rep. Dean, Madeleine [D-PA-4]

    PA • D

    Sponsored 8/2/2022

  • Rep. Schrader, Kurt [D-OR-5]

    OR • D

    Sponsored 10/21/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation